Contact this trialFirst, we need to learn more about you.
IDH2 Inhibitor
Enasidenib for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Denver, Colorado
This trial is testing the side effects of enasidenib and how well it works in treating patients with acute myeloid leukemia that has come back after treatment or has been difficult to treat with chemotherapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service